English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Capturing unbound drug exposure in the brain is crucial to evaluate pharmacological effects for drugs acting on the central nervous system. However, to date, there are no reports of validated prediction models to determine the brain-to-plasma unbound concentration ratio (K p,uu,brain ) as well as the cerebrospinal fluid (CSF)-to-plasma unbound concentration ratio (K p,uu,CSF ) between humans and other species. Here, we developed a translational CNS steady-state drug disposition model to predict K p,uu,brain  and K p,uu,CSF  across rats, monkeys, and humans by estimating the relative activity factors (RAF) for MDR1 and BCRP in addition to scaling factors ( γ  and  σ ) using the molecular weight, logD, CSF bulk flow, and  in vitro  transport activities of these transporters. In this study, 68, 26, and 28 compounds were tested in the rat, monkey, and human models, respectively. Both the predicted K p,uu,brain  and K p,uu,CSF  values were within the 3-fold range of the observed values (71, 73, and 79%; 79, 88, and 78% of the compounds, respectively), indicating successful prediction of K p,uu,brain  and K p,uu,CSF  in the three species. The overall predictivity of the RAF approach is consistent with that of the relative expression factor (REF) approach. As the established model can predict K p,uu,brain  and K p,uu,CSF  using only  in vitro  and physicochemical data, this model would help avoid ethical issues related to animal use and improve CNS drug discovery workflow.   Supplementary Information  The online version contains supplementary material available at 10.1208/s12248-021-00609-6.

the aaps journal

Translational CNS Steady-State Drug Disposition Model in Rats, Monkeys, and Humans for Quantitative Prediction of Brain-to-Plasma and Cerebrospinal Fluid-to-Plasma Unbound Concentration Ratios